Effects of Ecabet Sodium on Acute Mixed Reflux Esophagitis in Rats

References

• Onoda Y, Magaribuchi T, Tamaki H. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric secretion and experimental ulcers in rats. Jpn J Pharmacol 1989;51:65–73.
   PubMedGoogle Scholar
• Onoda Y, Magaribuchi T, Tamaki H. Effects of the new anti-ulcer agent 12-sulfodehydroabietic acid monosodium salt on duodenal alkaline secretion in rats. Arzneimittelforschung 1990;40:576–8.
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Iwasaki H, Yasoshita A, Tamaki H. Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats. Biol Pharm Bull 1993;16:1220–5.
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Kume E, Tamaki H. Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium. J Pharmacol Exp Ther 1995;275:494–501.
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Tamaki H. Possible mechanism of increase in gastric mucosal PGE2 and PGI2 generation induced by ecabet sodium, a novel gastroprotective agent. Dig Dis Sci 1997;42:83–90.
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Ishihara K, Hayashida H, Hiruma H, Saigenji K, Hotta K. Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa. Dig Dis Sci 2000;45:606–13.
   PubMed Web of Science ®Google Scholar
• Ito Y, Fukushima T, Sugawara Y, Takaiti O, Nakamura S. Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)-1,2,3,4,4a,9,10,10a-octahydro-1,4a- dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). I. Disposition, metabolism and protein binding in rats and dogs. J Pharmacobiodyn 1991;14:533–46.
   PubMedGoogle Scholar
• Ito Y, Sugawara Y, Takaiti O, Nakamura S. Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)-1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). II. Distribution in the rat stomach. J Pharmacobiodyn 1991;14:547–54.
   PubMedGoogle Scholar
• Kinoshita M, Yamasaki K, Kokusenya Y, Tamaki H. Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats. Comparison with sucralfate. Dig Dis Sci 1995;40:661–7.
   PubMed Web of Science ®Google Scholar
• Murata H, Kawano S, Tsuji S, Kamada T, Matsuzawa Y, Katsu K, Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer: prospective randomized multicenter study. J Gastroenterol Hepatol 2003;18:1029–33.
   PubMed Web of Science ®Google Scholar
• Kono T, Nomura M, Kasai S, Kohgo Y. Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study. Am J Gastroenterol 2001;96:793–7.
   PubMed Web of Science ®Google Scholar
• Nagahama K, Yamato M, Nishio H, Takeuchi K. Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats. Dig Dis Sci 2006;51:303–9.
   PubMed Web of Science ®Google Scholar
• Omura N, Kashiwagi H, Chen G, Yano F, Suzuki Y, Aoki T. Effects of ecabet sodium on experimentally induced reflux esophagitis. J Gastroenterol 2000;35:504–9.
   PubMed Web of Science ®Google Scholar
• Stoker DL, Williams JG. Alkaline reflux oesophagitis. Gut 1991;32:1090–2.
   PubMed Web of Science ®Google Scholar
• Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995;222:525–33.
   PubMed Web of Science ®Google Scholar
• Vaezi MF, Richter JE. Contribution of acid and duodenogastro-oesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients. Gut 1997;41:297–302.
   PubMed Web of Science ®Google Scholar
• Gillen P, Keeling P, Byrne PJ, Healy M, O’Moore RR, Hennecy TP. Implication of duodenogastric reflux in the pathogenesis of Barrett’s oesophagus. Br J Surg 1988;75:540–3.
   PubMed Web of Science ®Google Scholar
• D’Onofrio V, Bovero E, Iaquinto G. Characterization of acid and alkaline reflux in patients with Barrett’s esophagus. GOSPE Operative Group for the Study of Esophageal Precancer. Dis Esophagus 1997;10:16–23.
   PubMedGoogle Scholar
• Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology 1994;107:747–54.
   PubMed Web of Science ®Google Scholar
• Fein M, Peters JH, Chandrasoma P, Ireland AP, Ritter MP, Bremner CG, Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 1998;2:260–8.
   PubMedGoogle Scholar
• Mud HJ, Kranendonk SE, Obertop H, Van Houten H, Westbroek DL. Active trypsin and reflux oesophagitis: an experimental study in rats. Br J Surg 1982;69:269–72.
   PubMed Web of Science ®Google Scholar
• Johnson LF, Harmon JW. Experimental esophagitis in a rabbit model: clinical relevance. J Clin Gastroenterol 1986;8suppl 126–44.
   PubMedGoogle Scholar
• Okuyama K, Kinoshita M, Saito N, Kume E, Noto T, Nagasaki M. Effect of ecabet sodium on esophageal lesion induced by the reflux of gastric juice in rats. Jpn Pharmacol Ther 2005;33:1073–81.
   Google Scholar
• Naito Y, Uchiyama K, Kuroda M, Takagi T, Kokura S, Yoshida N, Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats. J Gastroenterol 2006;41:198–208.
   PubMed Web of Science ®Google Scholar